Orris
attachment
attachment

Tel about drug

analyse_media
Reading File
Finding Sources
Searching the Web

GHK-Cu copper tripeptide-1 mechanism of action pharmacology uses

Searching PubMed

GHK-Cu copper tripeptide biological activity

Here is a detailed overview of GHK-Cu (Copper Tripeptide-1) as shown on the packaging:

GHK-Cu - Copper Tripeptide-1

Manufacturer: Neolpharma (Grupo Farmacéutico) Strength: 50 mg | Pack: 5 boxes

What Is It?

GHK-Cu is a naturally occurring tripeptide made of three amino acids - Glycine (G), Histidine (H), and Lysine (K) - complexed with a copper (Cu²+) ion. It was first discovered in 1973 by Dr. Loren Pickart. It is naturally present in human plasma, saliva, and urine, but declines significantly with age. In the body, it functions as a signaling molecule that modulates gene expression.
The product in the image is a synthetic, pharmaceutical-grade (high purity) version used in research and clinical/aesthetic medicine.

Mechanism of Action

Unlike older assumptions that GHK-Cu worked simply by transporting copper into tissues, its primary mechanism is gene regulation - it modulates the expression of over 4,000 human genes, including:
  • Upregulating genes involved in tissue repair, collagen synthesis, and anti-oxidant defense
  • Downregulating genes involved in inflammation and tumor promotion
  • Stimulating release of growth factors: VEGF (vascular endothelial growth factor), BDNF (brain-derived neurotrophic factor), and BMP-2 (bone morphogenetic protein 2)
  • Modulating matrix metalloproteinases (MMPs) to balance tissue remodeling

Key Uses & Benefits

AreaEffect
Skin / Anti-agingStimulates collagen and elastin production; reduces wrinkles and fine lines; improves firmness
Wound healingAccelerates all phases of wound repair (inflammatory, proliferative, remodeling)
Hair lossPromotes hair follicle growth; used in hair loss treatments
Anti-inflammatoryInhibits NF-kB pathway; reduces inflammatory cytokines
AntioxidantNeutralizes free radicals; protects cells from oxidative damage
Post-procedure recoveryWidely used after microneedling, laser resurfacing, RF procedures
NeuroprotectionStimulates BDNF; explored for neurological applications
Musculoskeletal repairUnder research for tissue and tendon healing

Regulatory Status

  • NOT an FDA-approved drug. GHK-Cu is a research peptide / cosmetic/aesthetic compound.
  • Used legally in topical cosmetics (INCI name: Copper Tripeptide-1)
  • The injectable/injectable-grade form (like this 50 mg product from Neolpharma) is used in research settings or compounding pharmacies in some countries
  • Neolpharma is a legitimate Mexican pharmaceutical group, but this specific product is marketed as a research compound

Safety & Side Effects

  • Generally considered well-tolerated
  • Topical use: very low risk
  • Injectable use (research context): less studied; potential risks include site reactions
  • One caution: GHK-Cu promotes cell growth broadly - some researchers flag a theoretical concern about use in individuals with active cancer or high cancer risk, since the growth-promoting effects could theoretically stimulate tumor growth (though direct evidence is limited)
  • Increased facial/body hair growth can occur as a side effect with topical use

Recent Research (PubMed 2025-2026)

Recent studies continue to explore GHK-Cu's properties:
Most published research remains in the preclinical (animal/cell) stage - large-scale human clinical trials are still limited.
Disclaimer: GHK-Cu at this concentration (50 mg injectable-grade) is a research compound. It is not approved as a drug by the FDA or most regulatory agencies. Use should be under medical supervision. Do not self-administer without consulting a qualified healthcare provider.
This is a shared conversation. Sign in to Orris to start your own chat.